Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
339M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
151M
-
Shares change
-
+3.3M
-
Total reported value, excl. options
-
$1.5B
-
Value change
-
+$33.7M
-
Put/Call ratio
-
1.42
-
Number of buys
-
52
-
Number of sells
-
-37
-
Price
-
$9.94
Significant Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q3 2021
116 filings reported holding NUVB - Nuvation Bio Inc. - Common Stock as of Q3 2021.
Nuvation Bio Inc. - Common Stock (NUVB) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 151M shares
of 339M outstanding shares and own 44.6% of the company stock.
Largest 10 shareholders include FMR LLC (32.1M shares), Omega Fund Management, LLC (28.2M shares), EcoR1 Capital, LLC (13.7M shares), VANGUARD GROUP INC (11.9M shares), BAUPOST GROUP LLC/MA (8.62M shares), Avidity Partners Management LP (7.26M shares), CITADEL ADVISORS LLC (5.65M shares), BlackRock Inc. (5.4M shares), Redmile Group, LLC (4.54M shares), and BOXER CAPITAL, LLC (4.34M shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.